IFF Reports First Quarter 2020 Results
First Quarter 2020 Consolidated Summary:
Reported (GAAP) |
|
Adjusted (Non-GAAP)1 |
||||||||||
Sales |
|
Operating Profit |
|
EPS |
|
Sales |
|
Operating Profit |
|
EPS |
|
EPS ex Amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
¹ Schedules at the end of this release contain reconciliations of reported GAAP to non-GAAP metrics.
Management Commentary
“I am incredibly proud of how everyone at IFF has delivered for our customers around the world through the most challenging of circumstances," said
“Our ability to pivot quickly and adapt our daily operations has enabled us to responsibly operate our business while continuing to meet customer demand, despite a few logistics hurdles around the world. As regulatory restrictions aimed at protecting public health shifted worldwide through the quarter, we have worked through these challenges to realize minimal disruption across our production and supply chain. Protecting the health and safety of our colleagues, especially those still coming to our facilities, continues to be paramount as we navigate the challenges presented by COVID 19."
IFF Executive Vice President and CFO,
First Quarter 2020 Consolidated Financial Results
-
Reported net sales for the first quarter totaled
$1.35 billion , an increase of 4% from$1.30 billion in 2019. Currency neutral sales increased 6% driven by broad-based growth in Scent and Taste. -
Reported operating profit for the first quarter was
$196.2 million , an increase of 20% from$163.9 million in 2019. Excluding those items that affect comparability, adjusted operating profit excluding amortization increased 9% on a currency neutral basis led by volume growth, productivity initiatives and integration related synergies. -
Reported earnings per share (EPS) for the first quarter was
$1.15 per diluted share versus$0.96 per diluted share reported in 2019. Excluding those items that affect comparability, adjusted EPS excluding amortization was$1.62 per diluted share in 2020 versus$1.57 in the year-ago period. On a currency neutral basis, adjusted EPS excluding amortization increased 13% driven by adjusted operating profit growth, lower year-over-year interest expense and a more favorable effective tax rate.
First Quarter 2020 Segment Summary¹ : Growth vs. Prior Year
|
Reported (GAAP) |
|
Currency Neutral (Non-GAAP) |
||||
|
Sales |
|
Segment Profit |
|
Sales |
|
Segment Profit |
Scent |
5% |
|
17% |
|
7% |
|
19% |
Taste |
3% |
|
5% |
|
5% |
|
6% |
¹ Starting this quarter, IFF reports financial results in two segments, Taste and Scent, incorporating nearly all of the Frutarom business into the Taste segment.
Scent Segment
-
On a reported basis, sales increased 5%, or
$24.4 million , to$517.0 million . Currency neutral sales improved 7%, with growth in nearly all regions and all categories. Performance was driven by double-digit growth in Consumer Fragrance and high single-digit growth in Fragrance Ingredients. Fine Fragrance declined versus the prior year period, as the temporary closure of retail sites due to COVID-19 led to a deceleration in performance late in the quarter. - Scent segment profit increased 17% on a reported basis and grew 19% on a currency neutral basis driven by volume growth and the benefits of productivity initiatives.
Taste Segment
-
On a reported basis, sales increased 3%, or
$25.5 million , to$830.3 million . Currency neutral sales increased approximately 5% with growth in all regions and nearly all categories. Performance was driven by double-digit growth in Savory Solutions and Inclusions as well as low single digit growth in Flavors and Natural Products Solutions. Standalone legacy Frutarom sales growth in the quarter would have been approximately 4%. - Taste segment profit increased 5% on a reported basis and 6% on a currency neutral basis led by volume growth and integration-related synergies.
Business Environment Update Amid COVID-19
As the COVID-19 pandemic has spread globally, IFF is experiencing significant demand for ingredients and solutions used in certain consumer products, including packaged food, beverage and hygiene and disinfection, which represents approximately 85% of the Company’s total 2019 revenue. At the same time, IFF is seeing weakness across other offerings exposed to temporary disruptions of consumer access to retail markets, such as Fine Fragrance and Cosmetic Actives, and away-from-home channels, such as Food Service.
IFF continues to adapt quickly to the current environment, with a focus on mitigating the near-term impact while positioning for continued long-term success following the crisis and remains optimistic on seeing improvement as the pandemic abates.
2020 Full Year Financial Guidance:
As the COVID-19 pandemic continues to evolve, there is uncertainty around its ultimate impact; therefore, the Company's full year financial results cannot be reasonably estimated at this time and have been withdrawn.
Audio Webcast
A live webcast to discuss the Company’s first quarter 2020 financial results will be held on
Cautionary Statement Under The Private Securities Litigation Reform Act of 1995
This press release includes “forward-looking statements” under the Federal Private Securities Litigation Reform Act of 1995, including statements regarding the expected impact of the COVID 19 pandemic on the Company’s near term results, including sales and profit in the second quarter of 2020, and revenue from its categories with retail channel exposure, such as Fine Fragrance, Cosmetic Actives and Food Service; the expected impact of the COVID 19 pandemic on the global economy; the Company’s expectations with respect to generating cash flow and its liquidity position to manage a prolonged global economic downturn; anticipated increased costs relating to managing through the COVID 19 pandemic; expected updates from the Company on future performance and outlook for the business in 2020; the Company’s ability to manage through the COVID 19 pandemic and to mitigate the near-term impact; and the Company’s belief that it will see improvement in its business as the pandemic abates. These forward-looking statements are qualified in their entirety by cautionary statements and risk factor disclosures contained in the Company’s
Use of Non-GAAP Financial Measures
We provide in this press release non-GAAP financial measures, including: (i) currency neutral sales; (ii) adjusted operating profit; (iii) adjusted operating profit (margin) ex. amortization; (iv) adjusted EPS; (v) adjusted EPS ex. amortization and (vi) currency neutral adjusted EPS ex amortization.
Our non-GAAP financial measures are defined below.
Currency Neutral metrics eliminate the effects that result from translating international currency to
Adjusted Operating Profit excludes the impact of operational improvement initiatives, integration related costs, restructuring and other charges, net, losses (gains) on sale of assets, Frutarom acquisition related costs, compliance review & legal defense costs, and N&B transaction related costs ("Operating Profit Items Impacting Comparability").
Adjusted Operating Profit (Margin) ex. Amortization excludes the impact of Operating Profit Items Impacting Comparability and the amortization of acquisition related intangible assets.
Adjusted EPS excludes the impact of operational improvement initiatives, integration related costs, restructuring and other charges, net, losses (gains) on sale of assets, Frutarom acquisition related costs, compliance review & legal defense costs, N&B transaction related costs, and redemption value adjustment to EPS (often referred to as “Items Impacting Comparability”).
Adjusted EPS ex. Amortization excludes the impact of Items Impacting Comparability and the amortization of acquisition related intangible assets.
These non-GAAP measures are intended to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. In discussing our historical and expected future results and financial condition, we believe it is meaningful for investors to be made aware of and to be assisted in a better understanding of, on a period-to-period comparable basis, financial amounts both including and excluding these identified items, as well as the impact of exchange rate fluctuations. These non-GAAP measures should not be considered in isolation or as substitutes for analysis of the Company’s results under GAAP and may not be comparable to other companies’ calculation of such metrics.
In the fourth quarter of fiscal year 2018, we began including Adjusted EPS ex. Amortization as a key non-GAAP financial measure of our business. Full amortization expense of intangible assets acquired in connection with acquisitions will be excluded from Adjusted EPS ex. Amortization calculation. The exclusion of amortization expense allows comparison of operating results that are consistent over time for newly and long-held businesses and with both acquisitive and non-acquisitive peer companies. We believe this calculation will provide a more accurate presentation in this and in future periods in the event of additional acquisitions. Further, this allows the investors to evaluate and understand operating trends excluding the impact on operating income and earnings per diluted share. In addition, the Frutarom acquisition related costs and N&B transaction related costs have been separated from costs related to prior acquisitions. The Frutarom acquisition related costs and N&B transaction related costs represent a significant balance and we believe this amount should be shown separately to provide an accurate presentation of the acquisition related costs. Our GAAP results and GAAP metrics do not change, and this change has no effect on day to day business operations, or how we manage our business.
Welcome to IFF
At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), we’re using Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, we put science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products our world craves. Learn more at www.iff.com, Twitter, Facebook, Instagram, and LinkedIn.
Consolidated Income Statement
(Amounts in thousands except per share data)
(Unaudited)
|
Three Months Ended |
|||||||||
|
2020 |
|
2019 |
|
% Change |
|||||
Net sales |
$ |
1,347,317 |
|
|
$ |
1,297,402 |
|
|
4 |
% |
Cost of goods sold |
781,450 |
|
|
766,143 |
|
|
2 |
% |
||
Gross profit |
565,867 |
|
|
531,259 |
|
|
7 |
% |
||
Research and development expenses |
85,909 |
|
|
90,596 |
|
|
(5 |
)% |
||
Selling and administrative expenses |
229,714 |
|
|
213,182 |
|
|
8 |
% |
||
Amortization of acquisition-related intangibles |
48,350 |
|
|
47,625 |
|
|
2 |
% |
||
Restructuring and other charges, net |
4,918 |
|
|
16,174 |
|
|
(70 |
)% |
||
Losses (gains) on sales of fixed assets |
754 |
|
|
(188 |
) |
|
NMF |
|||
Operating profit |
196,222 |
|
|
163,870 |
|
|
20 |
% |
||
Interest expense |
32,140 |
|
|
36,572 |
|
|
(12 |
)% |
||
Other loss (income), net |
10,574 |
|
|
(7,278 |
) |
|
NMF |
|||
Income before taxes |
153,508 |
|
|
134,576 |
|
|
14 |
% |
||
Taxes on income |
26,297 |
|
|
23,362 |
|
|
13 |
% |
||
Net income |
127,211 |
|
|
111,214 |
|
|
14 |
% |
||
Net income attributable to noncontrolling interest |
2,604 |
|
|
2,385 |
|
|
9 |
% |
||
Net income attributable to IFF |
124,607 |
|
|
108,829 |
|
|
14 |
% |
||
|
|
|
|
|
|
|||||
Net income per share - basic (1) |
$ |
1.16 |
|
|
$ |
0.97 |
|
|
|
|
Net income per share - diluted (1) |
$ |
1.15 |
|
|
$ |
0.96 |
|
|
|
|
|
|
|
|
|
|
|||||
Average number of shares outstanding - basic |
112,082 |
|
|
111,864 |
|
|
|
|||
Average number of shares outstanding - diluted |
113,594 |
|
|
113,389 |
|
|
|
(1) For 2020 and 2019, net income per share reflects adjustments related to the redemption value of certain redeemable noncontrolling interests.
NMF Not meaningful
Condensed Consolidated Balance Sheet
(Amounts in thousands)
(Unaudited)
|
|
|
|
||||
|
2020 |
|
2019 |
||||
Cash, cash equivalents, and restricted cash |
$ |
442,945 |
|
|
$ |
623,945 |
|
Receivables |
943,114 |
|
|
876,197 |
|
||
Inventories |
1,075,913 |
|
|
1,123,068 |
|
||
Other current assets |
356,322 |
|
|
319,334 |
|
||
Total current assets |
2,818,294 |
|
|
2,942,544 |
|
||
|
|
|
|
||||
Property, plant and equipment, net |
1,339,124 |
|
|
1,386,920 |
|
||
|
7,945,005 |
|
|
8,349,531 |
|
||
Other assets |
586,653 |
|
|
608,416 |
|
||
Total assets |
12,689,076 |
|
|
13,287,411 |
|
||
|
|
|
|
||||
Short term borrowings |
$ |
385,569 |
|
|
$ |
384,958 |
|
Other current liabilities |
1,041,426 |
|
|
1,167,232 |
|
||
Total current liabilities |
1,426,995 |
|
|
1,552,190 |
|
||
|
|
|
|
||||
Long-term debt |
3,946,905 |
|
|
3,997,438 |
|
||
Non-current liabilities |
1,371,789 |
|
|
1,409,192 |
|
||
|
|
|
|
||||
Redeemable noncontrolling interests |
102,713 |
|
|
99,043 |
|
||
|
|
|
|
||||
Shareholders' equity |
5,840,674 |
|
|
6,229,548 |
|
||
Total liabilities and shareholders' equity |
$ |
12,689,076 |
|
|
$ |
13,287,411 |
|
Consolidated Statement of Cash Flows
(Amounts in thousands)
(Unaudited)
|
Three Months Ended |
||||||
|
2020 |
|
2019 |
||||
Cash flows from operating activities: |
|
|
|
||||
Net income |
$ |
127,211 |
|
|
$ |
111,214 |
|
Adjustments to reconcile to net cash provided by operating activities |
|
|
|
||||
Depreciation and amortization |
80,595 |
|
|
81,775 |
|
||
Deferred income taxes |
2,221 |
|
|
(12,389 |
) |
||
Losses (gains) on sale of assets |
754 |
|
|
(188 |
) |
||
Stock-based compensation |
8,624 |
|
|
7,604 |
|
||
Pension contributions |
(5,397 |
) |
|
(3,956 |
) |
||
Changes in assets and liabilities, net of acquisitions: |
|
|
|
||||
Trade receivables |
(133,291 |
) |
|
(55,935 |
) |
||
Inventories |
(568 |
) |
|
(24,719 |
) |
||
Accounts payable |
(31,635 |
) |
|
8,988 |
|
||
Accruals for incentive compensation |
(19,340 |
) |
|
(36,969 |
) |
||
Other current payables and accrued expenses |
(65,158 |
) |
|
(11,321 |
) |
||
Other assets |
42,462 |
|
|
(9,978 |
) |
||
Other liabilities |
10,467 |
|
|
(6,894 |
) |
||
Net cash provided by operating activities |
16,945 |
|
|
47,232 |
|
||
Cash flows from investing activities: |
|
|
|
||||
Cash paid for acquisitions, net of cash received |
— |
|
|
(33,895 |
) |
||
Additions to property, plant and equipment |
(48,294 |
) |
|
(57,609 |
) |
||
Proceeds from life insurance contracts |
1,739 |
|
|
1,890 |
|
||
Proceeds from disposal of assets |
3,806 |
|
|
3,970 |
|
||
Contingent consideration paid |
— |
|
|
(4,655 |
) |
||
Net cash used in investing activities |
(42,749 |
) |
|
(90,299 |
) |
||
Cash flows from financing activities: |
|
|
|
||||
Cash dividends paid to shareholders |
(80,038 |
) |
|
(77,779 |
) |
||
Increase in revolving credit facility and short term borrowings |
169 |
|
|
2,895 |
|
||
Repayments on debt |
(11,584 |
) |
|
(36,156 |
) |
||
Purchases of redeemable noncontrolling interest |
(14,173 |
) |
|
— |
|
||
Contingent consideration paid |
(327 |
) |
|
— |
|
||
Proceeds from issuance of stock in connection with stock options |
— |
|
|
200 |
|
||
Employee withholding taxes paid |
(1,275 |
) |
|
(1,339 |
) |
||
Net cash used in financing activities |
(107,228 |
) |
|
(112,179 |
) |
||
Effect of exchange rates changes on cash, cash equivalents and restricted cash |
(42,529 |
) |
|
3,853 |
|
||
Net change in cash, cash equivalents and restricted cash |
(175,561 |
) |
|
(151,393 |
) |
||
Cash, cash equivalents and restricted cash at beginning of year |
623,945 |
|
|
648,522 |
|
||
Cash, cash equivalents and restricted cash at end of period |
$ |
448,384 |
|
|
$ |
497,129 |
|
The following table reconciles cash, cash equivalents and restricted cash between the Company's statement of cash flows for the periods ended
|
|
|
|
|
|
|
|
||||||||
Current assets |
|
|
|
|
|
|
|
||||||||
Cash and cash equivalents |
$ |
433,246 |
|
|
$ |
606,823 |
|
|
$ |
483,504 |
|
|
$ |
634,897 |
|
Restricted cash |
9,699 |
|
|
17,122 |
|
|
13,625 |
|
|
13,625 |
|
||||
Noncurrent assets |
|
|
|
|
|
|
|
||||||||
Restricted cash included in Other assets |
5,439 |
|
|
— |
|
|
— |
|
|
— |
|
||||
Cash, cash equivalents and restricted cash |
$ |
448,384 |
|
|
$ |
623,945 |
|
|
$ |
497,129 |
|
|
$ |
648,522 |
|
Business Unit Performance
(Amounts in thousands)
(Unaudited)
|
Three Months Ended |
||||||
|
2020 |
|
2019 |
||||
|
|
|
|
||||
Taste |
$ |
830,322 |
|
|
$ |
804,802 |
|
Scent |
516,995 |
|
|
492,600 |
|
||
Consolidated |
$ |
1,347,317 |
|
|
$ |
1,297,402 |
|
|
|
|
|
||||
Segment Profit |
|
|
|
||||
Taste |
$ |
137,347 |
|
|
$ |
131,402 |
|
Scent |
105,395 |
|
|
89,953 |
|
||
Global Expenses |
(20,393 |
) |
|
(16,667 |
) |
||
Operational Improvement Initiatives |
— |
|
|
(406 |
) |
||
Frutarom Integration Related Costs |
(3,650 |
) |
|
(14,897 |
) |
||
Restructuring and Other Charges, net |
(4,918 |
) |
|
(16,174 |
) |
||
(Losses) gains on sale of assets |
(754 |
) |
|
188 |
|
||
Frutarom Acquisition Related Costs |
(813 |
) |
|
(9,529 |
) |
||
Compliance Review & Legal Defense Costs |
(649 |
) |
|
— |
|
||
N&B Transaction Related Costs |
(5,199 |
) |
|
— |
|
||
N&B Integration Related Costs |
(10,144 |
) |
|
— |
|
||
Operating profit |
196,222 |
|
|
163,870 |
|
||
Interest Expense |
(32,140 |
) |
|
(36,572 |
) |
||
Other loss (income), net |
(10,574 |
) |
|
7,278 |
|
||
Income before taxes |
$ |
153,508 |
|
|
$ |
134,576 |
|
|
|
|
|
||||
Operating Margin |
|
|
|
||||
Taste |
17 |
% |
|
16 |
% |
||
Scent |
20 |
% |
|
18 |
% |
||
Consolidated |
15 |
% |
|
13 |
% |
GAAP to Non-GAAP Reconciliation
Foreign Exchange Impact
(Unaudited)
Q1 Taste |
Sales |
|
Segment Profit |
|
% Change - Reported |
3% |
|
5% |
|
Currency Impact |
2% |
|
1% |
|
% Change - Currency Neutral |
5% |
|
6% |
|
|
|
|
|
|
Q1 Scent |
Sales |
|
Segment Profit |
|
% Change - Reported |
5% |
|
17% |
|
Currency Impact |
2% |
|
2% |
|
% Change - Currency Neutral |
7% |
|
19% |
|
|
|
|
|
|
Q1 Consolidated |
EPS ex. Amortization |
|
Adjusted Operating Profit |
|
% Change - Adjusted (Non-GAAP) |
3% |
|
7% |
|
Currency Impact |
10% |
|
2% |
|
% Change - Currency Neutral |
13% |
|
9% |
|
GAAP to Non-GAAP Reconciliation
(Unaudited)
The following information and schedules provide reconciliation information between reported GAAP amounts and non-GAAP certain adjusted amounts. This information and schedules are not intended as, and should not be viewed as, a substitute for reported GAAP amounts or financial statements of the Company prepared and presented in accordance with GAAP.
Reconciliation of Gross Profit |
|||||||
|
First Quarter |
||||||
(DOLLARS IN THOUSANDS) |
2020 |
|
2019 |
||||
Reported (GAAP) |
$ |
565,867 |
|
|
$ |
531,259 |
|
Operational Improvement Initiatives (a) |
— |
|
|
406 |
|
||
Frutarom Integration Related Costs (b) |
149 |
|
|
156 |
|
||
Frutarom Acquisition Related Costs (d) |
513 |
|
|
7,850 |
|
||
Adjusted (Non-GAAP) |
$ |
566,529 |
|
|
$ |
539,671 |
|
Reconciliation of Selling and Administrative Expenses |
|||||||
|
First Quarter |
||||||
(DOLLARS IN THOUSANDS) |
2020 |
|
2019 |
||||
Reported (GAAP) |
$ |
229,714 |
|
|
$ |
213,182 |
|
Frutarom Integration Related Costs (b) |
(3,279 |
) |
|
(14,557 |
) |
||
Frutarom Acquisition Related Costs (d) |
(300 |
) |
|
(1,679 |
) |
||
Compliance Review & Legal Defense Costs (e) |
(649 |
) |
|
— |
|
||
N&B Transaction Related Costs (f) |
(5,199 |
) |
|
— |
|
||
N&B Integration Related Costs (g) |
(10,144 |
) |
|
— |
|
||
Adjusted (Non-GAAP) |
$ |
210,143 |
|
|
$ |
196,946 |
|
Reconciliation of Operating Profit |
|||||||
|
First Quarter |
||||||
(DOLLARS IN THOUSANDS) |
2020 |
|
2019 |
||||
Reported (GAAP) |
$ |
196,222 |
|
|
$ |
163,870 |
|
Operational Improvement Initiatives (a) |
— |
|
|
406 |
|
||
Frutarom Integration Related Costs (b) |
3,650 |
|
|
14,897 |
|
||
Restructuring and Other Charges, net (c) |
4,918 |
|
|
16,174 |
|
||
Losses (Gains) on Sale of Assets |
754 |
|
|
(188 |
) |
||
Frutarom Acquisition Related Costs (d) |
813 |
|
|
9,529 |
|
||
Compliance Review & Legal Defense Costs (e) |
649 |
|
|
— |
|
||
N&B Transaction Related Costs (f) |
5,199 |
|
|
— |
|
||
N&B Integration Related Costs (g) |
10,144 |
|
|
— |
|
||
Adjusted (Non-GAAP) |
$ |
222,349 |
|
|
$ |
204,688 |
|
Reconciliation of Adjusted (Non-GAAP) Operating Profit Margin ex. Amortization |
|||||||
(DOLLARS IN THOUSANDS) |
First Quarter |
||||||
Numerator |
2020 |
|
2019 |
||||
Adjusted (Non-GAAP) Operating Profit |
$ |
222,349 |
|
|
$ |
204,688 |
|
Amortization of Acquisition related Intangible Assets |
48,350 |
|
|
47,625 |
|
||
Adjusted (Non-GAAP) Operating Profit ex. Amortization |
270,699 |
|
|
252,313 |
|
||
|
|
|
|
||||
Denominator |
|
|
|
||||
Sales |
1,347,317 |
|
|
1,297,402 |
|
||
Adjusted (Non-GAAP) Operating Profit Margin ex. Amortization |
20.1 |
% |
|
19.4 |
%
|
GAAP to Non-GAAP Reconciliation
(Unaudited)
The following information and schedules provide reconciliation information between reported GAAP amounts and non-GAAP certain adjusted amounts. This information and schedules are not intended as, and should not be viewed as, a substitute for reported GAAP amounts or financial statements of the Company prepared and presented in accordance with GAAP.
Reconciliation of Net Income |
|||||||||||||||||||||||||||||||
|
First Quarter |
||||||||||||||||||||||||||||||
|
2020 |
|
2019 |
||||||||||||||||||||||||||||
(DOLLARS IN THOUSANDS) |
Income before taxes |
|
Taxes on income (i) |
|
Net Income Attributable to IFF (j) |
|
Diluted EPS (k) |
|
Income before taxes |
|
Taxes on income (i) |
|
Net Income Attributable to IFF (j) |
|
Diluted EPS |
||||||||||||||||
Reported (GAAP) |
$ |
153,508 |
|
|
$ |
26,297 |
|
|
$ |
124,607 |
|
|
$ |
1.15 |
|
|
$ |
134,576 |
|
|
$ |
23,362 |
|
|
$ |
108,829 |
|
|
$ |
0.96 |
|
Operational Improvement Initiatives (a) |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
406 |
|
|
142 |
|
|
264 |
|
|
— |
|
||||||||
Frutarom Integration Related Costs (b) |
3,650 |
|
|
815 |
|
|
2,835 |
|
|
0.02 |
|
|
14,897 |
|
|
3,349 |
|
|
11,548 |
|
|
0.10 |
|
||||||||
Restructuring and Other Charges, net (c) |
4,918 |
|
|
1,034 |
|
|
3,884 |
|
|
0.03 |
|
|
16,174 |
|
|
4,031 |
|
|
12,143 |
|
|
0.11 |
|
||||||||
Losses (Gains) on Sale of Assets |
754 |
|
|
189 |
|
|
565 |
|
|
— |
|
|
(188 |
) |
|
(43 |
) |
|
(145 |
) |
|
— |
|
||||||||
Frutarom Acquisition Related Costs (d) |
213 |
|
|
(1,634 |
) |
|
1,847 |
|
|
0.02 |
|
|
9,529 |
|
|
1,530 |
|
|
7,999 |
|
|
0.07 |
|
||||||||
Compliance Review & Legal Defense Costs (e) |
649 |
|
|
135 |
|
|
514 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||||||
N&B Transaction Related Costs (f) |
5,199 |
|
|
— |
|
|
5,199 |
|
|
0.05 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||||||
N&B Integration Related Costs (g) |
10,144 |
|
|
2,168 |
|
|
7,976 |
|
|
0.07 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||||||
Redemption value adjustment to EPS (h) |
— |
|
|
— |
|
|
— |
|
|
(0.05 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||||||
Adjusted (Non-GAAP) |
$ |
179,035 |
|
|
$ |
29,004 |
|
|
$ |
147,427 |
|
|
$ |
1.30 |
|
|
$ |
175,394 |
|
|
$ |
32,371 |
|
|
$ |
140,638 |
|
|
$ |
1.24 |
|
Reconciliation of Adjusted (Non-GAAP) EPS ex. Amortization |
|||||||
|
First Quarter |
||||||
(DOLLARS AND SHARE AMOUNTS IN THOUSANDS) |
2020 |
|
2019 |
||||
Numerator |
|
|
|
||||
Adjusted (Non-GAAP) Net Income |
$ |
147,427 |
|
|
$ |
140,638 |
|
Amortization of Acquisition related Intangible Assets |
48,350 |
|
|
47,625 |
|
||
Tax impact on Amortization of Acquisition related Intangible Assets (i) |
10,966 |
|
|
10,196 |
|
||
Amortization of Acquisition related Intangible Assets, net of tax (l) |
37,384 |
|
|
37,429 |
|
||
Adjusted (Non-GAAP) Net Income ex. Amortization |
184,811 |
|
|
178,067 |
|
||
|
|
|
|
||||
Denominator |
|
|
|
||||
Weighted average shares assuming dilution (diluted) |
113,594 |
|
|
113,389 |
|
||
Adjusted (Non-GAAP) EPS ex. Amortization |
$ |
1.62 |
|
|
$ |
1.57 |
|
(a) |
Represents accelerated depreciation related to a plant relocation in |
|
(b) |
Represents costs related to the integration of the Frutarom acquisition. For 2020, costs primarily related to advisory services, retention bonuses and performance stock awards. For 2019, costs principally related to advisory services. |
|
(c) |
For 2020, represents costs primarily related to the Frutarom Integration Initiative. For 2019, represents costs primarily related to the Frutarom Integration Initiative and the 2019 Severance Charges program. |
|
(d) |
Represents transaction-related costs and expenses related to the acquisition of Frutarom. For 2020, amount primarily includes earn-out payments, net of adjustments, amortization for inventory "step-up" costs and transaction costs principally related to the 2019 Acquisition Activity. For 2019, amount primarily includes amortization for inventory "step-up" costs and transaction costs. |
|
(e) |
Costs related to reviewing the nature of inappropriate payments and review of compliance in certain other countries. In addition, includes legal costs for related shareholder lawsuits. |
|
(f) |
Represents transaction costs and expenses related to the pending transaction with |
|
(g) |
Represents costs related to the integration of the pending transaction with |
|
(h) |
Represents the adjustment to EPS related to the excess of the redemption value of certain redeemable noncontrolling interests over their existing carrying value. |
|
(i) |
The income tax expense (benefit) on non-GAAP adjustments is computed in accordance with ASC 740 using the same methodology as the GAAP provision of income taxes. Income tax effects of non-GAAP adjustments are calculated based on the applicable statutory tax rate for each jurisdiction in which such charges were incurred, except for those items which are non-taxable or are subject to a valuation allowance for which the tax expense (benefit) was calculated at 0%. For fiscal years 2020 and 2019, these non-GAAP adjustments were not subject to foreign tax credits, but to the extent that such factors are applicable to any future non-GAAP adjustments we will take such factors into consideration in calculating the tax expense (benefit). |
|
(j) |
For 2020 and 2019, net income is reduced by income attributable to noncontrolling interest of |
|
(k) |
The sum of these items does not foot due to rounding. |
|
(l) |
Represents all amortization of intangible assets acquired in connection with acquisitions, net of tax. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005880/en/
Head of Investor Relations and Communications
212.708.7164
Michael.DeVeau@iff.com
Source: IFF